Decaffeinated green tea extract rich in epigallocatechin-3-gallate prevents fatty liver disease by increased activities of mitochondrial respiratory chain complexes in diet-induced obesity mice

Journal of Nutritional Biochemistry

Volumn 26, Issue 11, 2015, Pages 1348-1356

  Santamarina, Aline B ^a   Carvalho Silva, Milena ^b   Gomes, Lara M ^b   Okuda, Marcos H ^a   Santana, Aline A ^a   Streck, Emilio L ^b   Seelaender, Marilia ^c   Oller do Nascimento, Claudia M ^a   Ribeiro, Eliane B ^a   Lira, Fábio S ^d   Oyama, Lila Missae ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

EGCG; Insulin resistance; Mice; NAFLD; Obesity; Respiratory chain

Indexed keywords

EPIGALLOCATECHIN GALLATE; GLUCOSE; GREEN TEA EXTRACT; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR ALPHA; INSULIN RECEPTOR SUBSTRATE 1; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR ALPHA; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; MALATE DEHYDROGENASE; PLACEBO; PROTEIN KINASE B; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG; CATECHIN; CYTOKINE; ENZYME; TEA;

AEROBIC METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLORIMETRY; CONTROLLED STUDY; DIET INDUCED OBESITY; ENERGY EXPENDITURE; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FAT MASS; FATTY LIVER; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID STORAGE; MALE; MESENTERIC FAT; MITOCHONDRIAL RESPIRATION; MOUSE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PROTEIN EXPRESSION; RESPIRATORY CHAIN; RETROPERITONEAL FAT; SUPPLEMENTATION; WEIGHT GAIN; WESTERN BLOTTING; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; ANIMAL; BODY WEIGHT; CHEMISTRY; COMPLICATION; DIET THERAPY; DIETARY SUPPLEMENT; DRUG EFFECTS; GLUCOSE TOLERANCE TEST; LIPID DIET; LIVER; METABOLISM; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; PATHOLOGY; TEA;

ANIMALS; BODY WEIGHT; CATECHIN; CYTOKINES; DIET, HIGH-FAT; DIETARY SUPPLEMENTS; ENZYMES; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; LIVER; MALE; MICE; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; TEA;

EID: 84946474230     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2015.07.002     Document Type: Article

References (62)

1. Darnton-Hill I., Nishida C., James W. A life course approach to diet, nutrition and the prevention of chronic diseases. Public Health Nutr 2007, 7:101-121. 10.1079/PHN2003584.
2. Delarue J., Magnan C. Free fatty acids and insulin resistance. Curr Opin Clin Nutr Metab Care 2007, 10:142-148. 10.1097/MCO.0b013e328042ba90.
3. Woods S.C., Seeley R.J., Rushing P.A., D'Alessio D., Tso P. A controlled high-fat diet induces an obese syndrome in rats. J Nutr 2003, 133:1081-1087.
4. Mayén A.-L., Marques-Vidal P., Paccaud F., Bovet P., Stringhini S. Socioeconomic determinants of dietary patterns in low- and middle-income countries: a systematic review. Am J Clin Nutr 2014, 10.3945/ajcn.114.089029.
5. Charlton M.R., Burns J.M., Pedersen R.A., Watt K.D., Heimbach J.K., Dierkhising R.A., et al. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology 2011, 141:1249-1253. 10.1053/j.gastro.2011.06.061.
6. Erickson S.K. Nonalcoholic fatty liver disease. J Lipid Res 2009, 50:S412-S416. 10.1194/jlr.R800089-JLR200.
7. Masuoka H.C., Chalasani N. Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals. Ann N Y Acad Sci 2013, 1281:106-122. 10.1111/nyas.12016.
8. De Wit N.J.W., Afman L.A., Mensink M., Müller M. Phenotyping the effect of diet on non-alcoholic fatty liver disease. J Hepatol 2012, 57:1370-1373. 10.1016/j.jhep.2012.07.003.
9. Gaggini M., Morelli M., Buzzigoli E., DeFronzo R.A., Bugianesi E., Gastaldelli A. Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease. Nutrients 2013, 5:1544-1560. 10.3390/nu5051544.
10. Ye J. Mechanisms of insulin resistance in obesity. Front Med 2013, 7:14-24. 10.1007/s11684-013-0262-6.
11. Byrne C.D. Ectopic fat, insulin resistance and non-alcoholic fatty liver disease. Proc Nutr Soc 2013, 72:412-419. 10.1017/S0029665113001249.
12. Vigouroux C., Caron-Debarle M., Le Dour C., Magré J., Capeau J. Molecular mechanisms of human lipodystrophies: from adipocyte lipid droplet to oxidative stress and lipotoxicity. Int J Biochem Cell Biol 2011, 43:862-876. 10.1016/j.biocel.2011.03.002.
13. Gregor M.F., Hotamisligil G.S. Inflammatory mechanisms in obesity. Annu Rev Immunol 2011, 29:415-445. 10.1146/annurev-immunol-031210-101322.
14. Ceddia R.B. The role of AMP-activated protein kinase in regulating white adipose tissue metabolism. Mol Cell Endocrinol 2013, 366:194-203. 10.1016/j.mce.2012.06.014.
15. Stanhope K.L., Havel P.J. Fructose consumption: potential mechanisms for its effects to increase visceral adiposity and induce dyslipidemia and insulin resistance. Curr Opin Lipidol 2008, 19:16-24. 10.1097/MOL.0b013e3282f2b24a.
16. Shoelson S.E., Lee J., Goldfine A.B. Inflammation and insulin resistance. J Clin Invest 2006, 116:1793-1801. 10.1172/JCI29069.
17. Côté I., Ngo Sock E.T., Lévy E., Lavoie J.-M. An atherogenic diet decreases liver FXR gene expression and causes severe hepatic steatosis and hepatic cholesterol accumulation: effect of endurance training. Eur J Nutr 2013, 52:1523-1532. 10.1007/s00394-012-0459-5.
18. Aubert J., Begriche K., Knockaert L., Robin M.A., Fromenty B. Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: mechanisms and pathophysiological role. Clin Res Hepatol Gastroenterol 2011, 35:630-637. 10.1016/j.clinre.2011.04.015.
19. Sverdlov A.L., Elezaby A., Behring J.B., Bachschmid M.M., Luptak I., Tu V.H., et al. High fat, high sucrose diet causes cardiac mitochondrial dysfunction due in part to oxidative post-translational modification of mitochondrial complex II. J Mol Cell Cardiol 2014, 10.1016/j.yjmcc.2014.07.018.
20. Holmström M.H., Iglesias-Gutierrez E., Zierath J.R., Garcia-Roves P.M. Tissue-specific control of mitochondrial respiration in obesity-related insulin resistance and diabetes. Am J Physiol Endocrinol Metab 2012, 302:E731-E739. 10.1152/ajpendo.00159.2011.
21. Xiao J., Ho C.T., Liong E.C., Nanji A.A., Leung T.M., Lau T.Y.H. Epigallocatechin gallate attenuates fibrosis, oxidative stress, and inflammation in non-alcoholic fatty liver disease rat model through TGF/SMAD, PI3 K/Akt/FoxO1, and NF-kappa B pathways. Eur J Nutr 2014, 53:187-199. 10.1007/s00394-013-0516-8.
22. Cunha C.A., Lira F.S., Rosa Neto J.C., Pimentel G.D., Souza G.I.H., da Silva C.M.G., et al. Green tea extract supplementation induces the lipolytic pathway, attenuates obesity, and reduces low-grade inflammation in mice fed a high-fat diet. Mediators Inflamm 2013, 2013:635470. 10.1155/2013/635470.
23. Wang S., Moustaid-Moussa N., Chen L., Mo H., Shastri A., Su R., et al. Novel insights of dietary polyphenols and obesity. J Nutr Biochem 2014, 25:1-18. 10.1016/j.jnutbio.2013.09.001.
24. Costa S., Utan A., Cervellati R., Speroni E., Guerra M.C. Catechins: natural free-radical scavengers against ochratoxin A-induced cell damage in a pig kidney cell line (LLC-PK1). Food Chem Toxicol 2007, 45:1910-1917. 10.1016/j.fct.2007.04.008.
25. Kim H.-S., Quon M.J., Kim J.-A. New insights into the mechanisms of polyphenols beyond antioxidant properties; lessons from the green tea polyphenol, epigallocatechin 3-gallate. Redox Biol 2014, 2:187-195. 10.1016/j.redox.2013.12.022.
26. Bose M., Lambert J.D., Ju J., Reuhl K.R., Shapses S.A., Yang C.S. The major green tea polyphenol, (-)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice. J Nutr 2008, 138:1677-1683. 10.1016/j.bbi.2008.05.010.
27. Banach M.S., Dong Q., O'Brien P.J. Hepatocyte cytotoxicity induced by hydroperoxide (oxidative stress model) or glyoxal (carbonylation model): prevention by bioactive nut extracts or catechins. Chem Biol Interact 2009, 178:324-331. 10.1016/j.cbi.2008.10.003.
28. Murase T., Haramizu S., Shimotoyodome A., Nagasawa A., Tokimitsu I. Green tea extract improves endurance capacity and increases muscle lipid oxidation in mice. Am J Physiol Regul Integr Comp Physiol 2005, 288:R708-R715. 10.1152/ajpregu.00693.2004.
29. Reeves P.G., Nielsen F.H., Fahey G.C. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 1993, 123:1939-1951.
30. Turner R.C., Holman R.R., Matthews D., Hockaday T.D., Peto J. Insulin deficiency and insulin resistance interaction in diabetes: estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations. Metabolism 1979, 28:1086-1096. 10.1016/0026-0495(79)90146-x.
31. Folch J., Lees M., Sloane Stanley G.H. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957, 10.1371/journal.pone.0020510.
32. Cassina A., Radi R. Differential inhibitory action of nitric oxide and peroxynitrite on mitochondrial electron transport. Arch Biochem Biophys 1996, 328:309-316. 10.1006/abbi.1996.0178.
33. Fischer J.C., Ruitenbeek W., Berden J.A., Trijbels J.M.F., Veerkamp J.H., Stadhouders A.M., et al. Differential investigation of the capacity of succinate oxidation in human skeletal muscle. Clin Chim Acta 1985, 153:23-36. 10.1016/0009-8981(85)90135-4.
34. Rustin P., Bourgeron T., Munnich A., Enfant D.I. Endomyocardial biopsies for early detection of mitochondrial disorders in hypertrophic cardiomyopathies. J Pediatr 1994, 124:224-228.
35. Hughes B.P. A method for the estimation of serum creatine kinase and its use in comparing creatine kinase and aldolase activity in normal and pathological sera. Clin Chim Acta 1962, 7:597-603. 10.1016/0009-8981(62)90137-7.
36. An R., Burd N.A. Change in daily energy intake associated with pairwise compositional change in carbohydrate, fat and protein intake among US adults, 1999-2010. Public Health Nutr 2014, 18:1343-1352. 10.1017/S1368980014001876.
37. Swinburn B.A., Caterson I., Seidell J.C., James W.P. Diet, nutrition and the prevention of excess weight gain and obesity. Public Health Nutr 2007, 7:123-146. 10.1079/PHN2003585.
38. Steyn N.P., McHiza Z., Hill J., Davids Y.D., Venter I., Hinrichsen E., et al. Nutritional contribution of street foods to the diet of people in developing countries: a systematic review. Public Health Nutr 2014, 17:1363-1374. 10.1017/S1368980013001158.
39. Masquio D.C.L., de Piano A., Campos R.M.S., Sanches P.L., Corgosinho F.C., Carnier J., et al. Saturated fatty acid intake can influence increase in plasminogen activator inhibitor-1 in obese adolescents. Horm Metab Res 2014, 46:245-251. 10.1055/s-0034-1370908.
40. Jenkins Y., Sun T.-Q., Li Y., Markovtsov V., Uy G., Gross L., et al. Global metabolite profiling of mice with high-fat diet-induced obesity chronically treated with AMPK activators R118 or metformin reveals tissue-selective alterations in metabolic pathways. BMC Res Notes 2014, 7:674. 10.1186/1756-0500-7-674.
41. Mullen K.L., Pritchard J., Ritchie I., Snook L.A., Chabowski A., Bonen A., et al. Adiponectin resistance precedes the accumulation of skeletal muscle lipids and insulin resistance in high-fat-fed rats. Am J Physiol Regul Integr Comp Physiol 2009, 296:R243-R251. 10.1152/ajpregu.90774.2008.
42. Axen K.V., Dikeakos A., Sclafani A. High dietary fat promotes syndrome X in nonobese rats. J Nutr 2003, 133:2244-2249.
43. El Akoum S., Lamontagne V., Cloutier I., Tanguay J. Nature of fatty acids in high fat diets differentially delineates obesity-linked metabolic syndrome components in male and female C57BL/6J mice. Diabetol Metab Syndr 2011, 3:34. 10.1186/1758-5996-3-34.
44. Korou L.-M.a, Doulamis I.P., Tzanetakou I.P., Mikhailidis D.P., Perrea D.N. The effect of biological age on the metabolic responsiveness of mice fed a high-fat diet. Lab Anim 2013, 47:241-244. 10.1177/0023677213480768.
45. Buettner R., Parhofer K.G., Woenckhaus M., Wrede C.E., Kunz-Schughart L.A., Schölmerich J., et al. Defining high-fat-diet rat models: metabolic and molecular effects of different fat types. J Mol Endocrinol 2006, 10.1677/jme.1.01909.
46. Ciapaite J., van den Broek N.M., Te Brinke H., Nicolay K., Jeneson J.A., Houten S.M., et al. Differential effects of short- and long-term high-fat diet feeding on hepatic fatty acid metabolism in rats. Biochim Biophys Acta 2011, 1811:441-451. 10.1016/j.bbalip.2011.05.005.
47. Turner N., Kowalski G.M., Leslie S.J., Risis S., Yang C., Lee-Young R.S., et al. Distinct patterns of tissue-specific lipid accumulation during the induction of insulin resistance in mice by high-fat feeding. Diabetologia 2013, 56:1638-1648. 10.1007/s00125-013-2913-1.
48. Carillon J., Romain C., Bardy G., Fouret G., Feillet-Coudray C., Gaillet S., et al. Cafeteria diet induces obesity and insulin resistance associated with oxidative stress but not with inflammation: improvement by dietary supplementation with a melon superoxide dismutase. Free Radic Biol Med 2013, 65:254-261. 10.1016/j.freeradbiomed.2013.06.022.
49. Moon H.S., Lee H.G., Choi Y.J., Kim T.G., Cho C.S. Proposed mechanisms of (-)-epigallocatechin-3-gallate for anti-obesity. Chem Biol Interact 2007, 167:85-98. 10.1016/j.cbi.2007.02.008.
50. Kanwar J., Taskeen M., Mohammad I., Huo C., Chan T.H., Dou Q.P. Recent advances on tea polyphenols. Front Biosci (Elite Ed) 2012, 4:111-131.
51. Huang C.H., Tsai S.J., Wang Y.J., Pan M.H., Kao J.Y., Der Way T. EGCG inhibits protein synthesis, lipogenesis, and cell cycle progression through activation of AMPK in p53 positive and negative human hepatoma cells. Mol Nutr Food Res 2009, 53:1156-1165. 10.1002/mnfr.200800592.
52. Morino K., Petersen K.F., Shulman G.I. Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction. Diabetes 2006, 55. 10.2337/db06-S002.
53. Lowell B.B., Shulman G.I. Mitochondrial dysfunction and type 2 diabetes. Science 2005, 307:384-387. 10.1126/science.1104343.
54. Balaban R.S. The mitochondrial proteome: a dynamic functional program in tissues and disease states. Environ Mol Mutagen 2010, 51:352-359. 10.1002/em.20574.
55. Hoeks J., van Herpen N., Mensink M., Moonen-Kornips E., van Beurden D., Hesselink M.K.C., et al. Mitochondrial dysfunction as consequence rather than cause of human insulin resistance. Diabetes 2010, 59:2117-2125. 10.2337/db10-0519.J.H.
56. Crescenzo R., Bianco F., Falcone I., Prisco M., Liverini G., Iossa S. Alterations in hepatic mitochondrial compartment in a model of obesity and insulin resistance. Obesity (Silver Spring) 2008, 16:958-964. 10.1038/oby.2008.10.
57. Mantena S.K., Vaughn D.P., Andringa K.K., Eccleston H.B., King A.L., Abrams G., et al. High fat diet induces dysregulation of hepatic oxygen gradients and mitochondrial function in vivo. Biochem J 2009, 417:183-193. 10.1042/BJ20080868.
58. Iossa S., Lionetti L., Mollica M.P., Crescenzo R., Botta M., Barletta A., et al. Effect of high-fat feeding on metabolic efficiency and mitochondrial oxidative capacity in adult rats. Br J Nutr 2003, 90:953-960. 10.1079/BJN2003000968.
59. Suthammarak W., Morgan P.G., Sedensky M.M. Mutations in mitochondrial complex III uniquely affect complex I in Caenorhabditis elegans. J Biol Chem 2010, 285:40724-40731. 10.1074/jbc.M110.159608.
60. Satapati S., Sunny N.E., Kucejova B., Fu X., He T.T., Méndez-Lucas A., et al. Elevated TCA cycle function in the pathology of diet-induced hepatic insulin resistance and fatty liver. J Lipid Res 2012, 53:1080-1092. 10.1194/jlr.M023382.
61. Timmers S., Konings E., Bilet L., Houtkooper R.H., van de Weijer T., Goossens G.H., et al. Calorie restriction-like effects of 30days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab 2011, 14:612-622. 10.1016/j.cmet.2011.10.002.
62. Valdecantos M.P., Pérez-Matute P., González-Muniesa P., Prieto-Hontoria P.L., Moreno-Aliaga M.J., Martínez J.A. Lipoic acid administration prevents nonalcoholic steatosis linked to long-term high-fat feeding by modulating mitochondrial function. J Nutr Biochem 2012, 23:1676-1684. 10.1016/j.jnutbio.2011.11.011.